ArticleCureus2025
From Therapy to Toxicity: A Rare Case of Acute Piperacillin/Tazobactam-Associated Drug-Induced Liver Injury.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced liver injury (DILI) is a diagnosis of exclusion, but one that requires high clinical suspicion because prompt withdrawal of the offending agent is imperative to improve prognosis. Piperacillin/tazobactam (TZP) is a rare cause of clinically apparent liver injury. This case is an example of DILI caused by TZP that was identified when a hospitalized patient's liver enzymes greatly increased, and hepatic steatosis was subsequently seen on a computed tomography scan. The Roussel Uclaf Causality Assessment Method (RUCAM) score is a tool used to indicate the likelihood of DILI. In this case, the RUCAM score was 7, indicating that the causality assessment of the TZP as the cause of liver injury was probable. This case underscores the importance of maintaining a high index of suspicion for DILI, particularly in patients receiving extended courses of antibiotics, and highlights the need for routine liver function monitoring during therapy with agents known to carry hepatotoxic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.